Advertisement
UK markets close in 6 hours 42 minutes

  • FTSE 100

    8,305.55
    +92.06 (+1.12%)
     

  • FTSE 250

    20,373.60
    +209.06 (+1.04%)
     

  • AIM

    777.51
    +5.98 (+0.78%)
     

  • GBP/EUR

    1.1650
    -0.0010 (-0.08%)
     

  • GBP/USD

    1.2540
    -0.0024 (-0.19%)
     

  • Bitcoin GBP

    51,311.55
    -845.69 (-1.62%)
     

  • CMC Crypto 200

    1,331.63
    -33.50 (-2.45%)
     

  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     

  • DOW

    38,852.27
    +176.59 (+0.46%)
     

  • CRUDE OIL

    78.79
    +0.31 (+0.40%)
     

  • GOLD FUTURES

    2,323.80
    -7.40 (-0.32%)
     

  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     

  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     

  • DAX

    18,251.38
    +76.17 (+0.42%)
     

  • CAC 40

    8,017.06
    +20.42 (+0.26%)
     
Money:

The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

Cresco Labs to Report Fourth Quarter and Annual 2023 Financial Results on March 13, 2024

Business Wire
·2-min read

CHICAGO, February 27, 2024--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco" or "Company"), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the fourth quarter and year ended December 31st, 2023 on Wednesday, March 13th, 2024 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Fourth Quarter 2023 Earnings Conference Call
Date: Wednesday, March 13th, 2024
Time: 8:30 am EST
Webcast: LINK
Dial-in: 1-833-470-1428 (US Toll Free), 1-404-975-4839 (US Local)
Access Code: 614771

ADVERTISEMENT

Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.

About Cresco Labs Inc.

Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the Company is leveraging its scale and agility to grow its portfolio of brands that include Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy’s and Remedi, on a national level. The Company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering ongoing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, workforce development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible. Learn more about Cresco Labs’ journey by visiting www.crescolabs.com or following the Company on Facebook, X or LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240227005055/en/

Contacts

Media
Jason Erkes, Chief Communications Officer
press@crescolabs.com
312-953-2767

Investors
investors@crescolabs.com

General Inquiries
312-929-0993
info@crescolabs.com